CCL2 plays an important role in secondary injury after high-altitude ICH, mainly by amplifying inflammation and exacerbating damage via the CCL2-CCR2-NF-κB pathway and may serve as a potential therapeutic target.
Huang et al. (Wed,) studied this question.